Atlas Trials

ctDNA Screening in Advanced HER2 Positive Gastric Cancer

Clinical trial NCT04520295 · UNKNOWN

Trial details

NCT number
NCT04520295
Sponsor
Ruijin Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2-positive Gastric Cancer
Start date
2020-05-19
Primary completion
2023-05-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.